Neurosterix was spun-out of Addex in April 2024, raising $65 million in a Series A financing led by funds affiliated with ...

Addex spin-out Neurosterix begins phase 1 study with M4 PAM - NTX-253 for schizophrenia: Geneva, Switzerland Thursday, January 8, 2026, 12:00 Hrs [IST] Addex Therapeutics, a clini ...

Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, January 7, 2026 - Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...

Researchers at the University of São Paulo found that these effects become stronger when the molecule is used together with fluoride and xylitol, rather than on its own. An experimental artificial ...

Attorney General Pam Bondi could face a financial penalty every day over the Department of Justice’s (DOJ) failure to release all of its files on Jeffrey Epstein under a plan announced by ...

U.S. Attorney General Pam Bondi’s approval rating has declined by 47 points in 10 months, recent polls show. According to polling by AtlasIntel, the proportion of people who approve of Bondi has ...

Reps. Ro Khanna, D-Calif., and Thomas Massie, R-Ky., said Sunday they are committed to holding Justice Department officials accountable for their failure to release all eligible Jeffrey Epstein files ...

Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric ...

A pair of US lawmakers have threatened legal action against US Attorney General Pam Bondi, after her deadline to release all government files related to the late convicted sex offender Jeffrey Epstein ...

Two lawmakers are threatening a seldom-used congressional sanction against the Department of Justice over what they say is a failure to release all of its files on convicted sex offender Jeffrey ...